Evaluation of the TRPM2 channel as a biomarker inbreast cancer using public databases analysis
Background: Breast cancer is one of the most common malignancies affecting women. Recent investigations have revealed a major role of ion channels in cancer. The transient receptor potential melastatin-2 (TRPM2) is a plasma membrane and lysosomal channel with important roles in cell migration and...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Spanish / Castilian |
| Published: |
Hospital Infantil de México
2016
|
| Subjects: | |
| Online Access: | http://eprints.uanl.mx/14501/1/14.pdf |
| _version_ | 1824414064382574592 |
|---|---|
| author | Sumoza Toledo, Adriana Espinoza Gabriel, Mario Iván Montiel Condado, Dvorak |
| author_facet | Sumoza Toledo, Adriana Espinoza Gabriel, Mario Iván Montiel Condado, Dvorak |
| author_sort | Sumoza Toledo, Adriana |
| collection | Repositorio Institucional |
| description | Background: Breast cancer is one of the most common malignancies affecting women. Recent
investigations have revealed a major role of ion channels in cancer. The transient receptor
potential melastatin-2 (TRPM2) is a plasma membrane and lysosomal channel with important
roles in cell migration and cell death in immune cells and tumor cells.
Methods: In this study, we investigated the prognostic value of TRPM2 channel in breast cancer,
analyzing public databases compiled in OncomineTM (Thermo Fisher, Ann Arbor, MI) and online
Kaplan-Meier Plotter platforms.
Results: The results revealed that TRPM2 mRNA overexpression is significant in situ and invasive
breast carcinoma compared to normal breast tissue. Furthermore, multi-gene validation using
OncomineTM showed that this channel is coexpressed with proteins related to cellular migration,
transformation, and apoptosis. On the other hand, Kaplan-Meier analysis exhibited that low
expression of TRPM2 could be used to predict poor outcome in ER- and HER2+ breast carcinoma
patients.
Conclusions: TRPM2 is a promising biomarkerfor aggressiveness of breast cancer, and a potential
target for the development of new therapies. |
| format | Article |
| id | eprints-14501 |
| institution | UANL |
| language | Spanish / Castilian |
| publishDate | 2016 |
| publisher | Hospital Infantil de México |
| record_format | eprints |
| spelling | eprints-145012020-10-08T22:50:21Z http://eprints.uanl.mx/14501/ Evaluation of the TRPM2 channel as a biomarker inbreast cancer using public databases analysis Sumoza Toledo, Adriana Espinoza Gabriel, Mario Iván Montiel Condado, Dvorak RC Medicina Interna, Psiquiatría, Neurología Background: Breast cancer is one of the most common malignancies affecting women. Recent investigations have revealed a major role of ion channels in cancer. The transient receptor potential melastatin-2 (TRPM2) is a plasma membrane and lysosomal channel with important roles in cell migration and cell death in immune cells and tumor cells. Methods: In this study, we investigated the prognostic value of TRPM2 channel in breast cancer, analyzing public databases compiled in OncomineTM (Thermo Fisher, Ann Arbor, MI) and online Kaplan-Meier Plotter platforms. Results: The results revealed that TRPM2 mRNA overexpression is significant in situ and invasive breast carcinoma compared to normal breast tissue. Furthermore, multi-gene validation using OncomineTM showed that this channel is coexpressed with proteins related to cellular migration, transformation, and apoptosis. On the other hand, Kaplan-Meier analysis exhibited that low expression of TRPM2 could be used to predict poor outcome in ER- and HER2+ breast carcinoma patients. Conclusions: TRPM2 is a promising biomarkerfor aggressiveness of breast cancer, and a potential target for the development of new therapies. Hospital Infantil de México 2016 Article PeerReviewed text es cc_by_nc_nd http://eprints.uanl.mx/14501/1/14.pdf http://eprints.uanl.mx/14501/1.haspreviewThumbnailVersion/14.pdf Sumoza Toledo, Adriana y Espinoza Gabriel, Mario Iván y Montiel Condado, Dvorak (2016) Evaluation of the TRPM2 channel as a biomarker inbreast cancer using public databases analysis. Boletín médico del Hospital Infantil de México, 73 (6). pp. 397-404. ISSN 1665-1146 http://doi.org/10.1016/j.bmhimx.2017.11.001 doi:10.1016/j.bmhimx.2017.11.001 |
| spellingShingle | RC Medicina Interna, Psiquiatría, Neurología Sumoza Toledo, Adriana Espinoza Gabriel, Mario Iván Montiel Condado, Dvorak Evaluation of the TRPM2 channel as a biomarker inbreast cancer using public databases analysis |
| thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
| title | Evaluation of the TRPM2 channel as a biomarker inbreast cancer using public databases analysis |
| title_full | Evaluation of the TRPM2 channel as a biomarker inbreast cancer using public databases analysis |
| title_fullStr | Evaluation of the TRPM2 channel as a biomarker inbreast cancer using public databases analysis |
| title_full_unstemmed | Evaluation of the TRPM2 channel as a biomarker inbreast cancer using public databases analysis |
| title_short | Evaluation of the TRPM2 channel as a biomarker inbreast cancer using public databases analysis |
| title_sort | evaluation of the trpm2 channel as a biomarker inbreast cancer using public databases analysis |
| topic | RC Medicina Interna, Psiquiatría, Neurología |
| url | http://eprints.uanl.mx/14501/1/14.pdf |
| work_keys_str_mv | AT sumozatoledoadriana evaluationofthetrpm2channelasabiomarkerinbreastcancerusingpublicdatabasesanalysis AT espinozagabrielmarioivan evaluationofthetrpm2channelasabiomarkerinbreastcancerusingpublicdatabasesanalysis AT montielcondadodvorak evaluationofthetrpm2channelasabiomarkerinbreastcancerusingpublicdatabasesanalysis |